Henrike J. Westerink

Henrike J. Westerink

Auto-generated profile, based on publicly available information

Henrike J. Westerink

Department of Value Improvement, St. Antonius Hospital, Nieuwegein, Utrecht, the Netherlands; Scientific Center for Quality of Healthcare (IQ healthcare), Radboud University Medical Center, Nijmegen, the Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2023 in Health Policy
Verified
Journal Article
Open access
HWHenrike J. Westerink
Henrike J. Westerink
TOTom Oirbans
Tom Oirbans
MGMirjam M. Garvelink
Mirjam M. Garvelink
CUCornelia F. van Uden-Kraan
Cornelia F. van Uden-Kraan
OZOuisam Zouitni
Ouisam Zouitni
PNPaul B. van der Nat
Paul B. van der Nat
Collective patient participation, such as patient participation in policy making, has become increasingly important to achieve high-quality care. However, there is little knowledge on how to let patients participate in a meaningful manner at this level. The aim of this systematic literature review was to provide an overview of barriers, facilitators, and associated impact of collective patient participation. PubMed and EMBASE were searched until May 2023 for studies that evaluated collective patient participation. Study characteristics, methods for patient participation, barriers and facilitators, and impact (if measured) of patient participation were extracted from the articles. We included 59 articles. Identified barriers and facilitators of collective patient participation were grouped into five categories: (1) preconditions for patient participation, (2) strategy for patient participation, (3) preparation of patients and staff for patient participation, (4) support for patients and staff during patient participation, and (5) evaluation of patient participation. Impact of patient participation was reported in 34 included studies at three levels: quality of care and research, the team and organization, and the participants themselves. Only three studies reported quantitative outcomes. Interestingly, similar challenges were experienced during a period of twenty years, indicating that little progress has been made in structuring patient participation. Our overview of barriers and facilitators will therefore help to improve and structure collective patient participation.

21 February 2024 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
HWHenrike J. Westerink
Henrike J. Westerink
GSGijs Steinmann
Gijs Steinmann
MKMaarten Koomans
Maarten Koomans
MKMichèle H. van der Kemp
Michèle H. van der Kemp
PNPaul B. van der Nat
Paul B. van der Nat
Background: Many hospitals worldwide have set up multidisciplinary Value Improvement (VI) teams that use the Value-Based Health Care (VBHC) theory to improve patient value. However, it remains unclear what the level of VBHC implementation is within these teams. We therefore studied the current level of VBHC implementation in VI teams. Methods: A questionnaire was developed based on the strategic agenda for value transformation and real-world experiences with VBHC implementation. The questionnaire consisted of 21 questions, mapped to seven domains, and was sent out to 25 multidisciplinary VI teams. Median scores for individual questions (scale = 1–5) and average scores per domain were calculated. Results: One hundred forty VI team members completed the questionnaire. The overall average score is 3.49. The ‘culture and responsibility’ domain obtained the highest average score (µ = 4.11). The domain ‘measure and improve outcomes’ and the domain ‘multidisciplinary team’ obtained average scores that are slightly higher than the overall average (µ = 3.78 and µ = 3.76 respectively), and the domains ‘strategy and organizational policy,’ ‘collaboration and sharing,’ and ‘IT and data’ scored a little below the overall average (µ = 3.41, µ = 3.32, and µ = 3.29 respectively). The domain ‘costs and reimbursement’ obtained the lowest average score (µ = 2.42) of all domains, indicating that the implementation of this particular aspect of VBHC remains lagging behind. Conclusions: Our results indicate activity in each of the questionnaire domains. To bring VBHC implementation to the next level, more attention should be given to the financial aspects. Our questionnaire can be used in future studies to identify improvements or differences within VI teams.

18 January 2024 in Health Expectations
Verified
Journal Article
Open access
HWHenrike J. Westerink
Henrike J. Westerink
MGMirjam M. Garvelink
Mirjam M. Garvelink
CUCornelia F. van Uden‐Kraan
Cornelia F. van Uden‐Kraan
OZOuisam Zouitni
Ouisam Zouitni
HBHans A. J. Bart
Hans A. J. Bart
TGthe Santeon Patient Participation Study Group
the Santeon Patient Participation Study Group
Introduction: Value‐based healthcare (VBHC) focusses on increasing value for patients. Hospitals aim to implement VBHC via value improvement (VI) teams for medical conditions. To determine the patient's perspective on value, collective patient participation is important in these teams. We therefore evaluated the current state of patient participation in VI teams and share lessons learned.Methods: This mixed‐methods study was conducted at seven collaborating hospitals in the Netherlands. A questionnaire (the public and patient engagement evaluation tool) was tailored to the study's context, completed by VI team members (n = 147 from 76 different VI teams) and analysed with descriptive statistics. In addition, 30 semistructured interviews were held with VI team members and analysed through thematic analysis. Data were collected between February 2022 and January 2023 and were triangulated by mapping the quantitative results to the interview themes.Results: Thirty‐eight of the 76 included VI teams reported using a form of patient participation. Many respondents (71%) indicated a lack of a clear strategy and goal for patient participation. Multiple VI team members believed that specific knowledge and skills are required for patients to participate in a VI team, but this led to concerns regarding the representativeness of participating patients. Furthermore, while patients indicated that they experienced some level of hierarchy, they also stated that they did not feel restricted hereby. Lastly, patients were satisfied with their participation and felt like equal VI team members (100%), but they did mention a lack of feedback from the VI team on their input.Conclusion: The results imply the lack of full implementation of patient participation within VI teams. Guidelines should be developed that provide information on how to include a representative group of patients, which methods to use, how to evaluate the impact of patient participation, and how to give feedback to participating patients.Patient and Public Contribution: Two patient advisors were part of the research team and attended the research team meetings. They were involved as research partners in all phases of the study, including drafting the protocol (e.g., drafting interview guides and selecting the measurement instrument), interpreting the results and writing this article.

24 October 2022 in Expert Opinion on Drug Safety
Verified
Journal Article
Open access
HWHenrike J. Westerink
Henrike J. Westerink
LKLeanne J. Kosse
Leanne J. Kosse
NJNaomi Jessurun
Naomi Jessurun
ATAstrid van Tubergen
Astrid van Tubergen
HVHarald E. Vonkeman
Harald E. Vonkeman
MVMarieke de Vries
Marieke de Vries
Previous studies showed a discrepancy between health-care professionals’ (HCPs’) and patients’ perspective on adverse drug reaction (ADR) burden. However, it is unclear which factors make an ADR bu...

31 October 2023 in Patient Education and Counseling
Verified
Journal Article
Open access
HWHenrike J. Westerink
Henrike J. Westerink
CBCato C. Bresser
Cato C. Bresser
MGMirjam M. Garvelink
Mirjam M. Garvelink
CUCornelia F. van Uden-Kraan
Cornelia F. van Uden-Kraan
OZOuisam Zouitni
Ouisam Zouitni
PVPepijn H. van der Voort
Pepijn H. van der Voort
To gain insight into healthcare professionals' (HCPs') perspectives on the use of outcome data in consultations and to understand which aggregated outcomes patients find important. This study had a mixed-methods design and consisted of two steps: RESULTS: HCPs indicated that aggregated outcome data are not routinely used in consultations. They pointed out various barriers to using outcome data, e.g., low response rates of PROMs, and suggested actions to address these barriers, including training of HCPs in outcome data usage. Patients rated the majority of aggregated outcomes as important, although preferences differed between the studied health conditions. Both HCPs and patients underscored the importance of discussing outcome data in consultations. Nevertheless, HCPs encountered several barriers to using outcome data. Furthermore, patients with different health conditions have somewhat different information needs. The study identified several actionable steps to enhance the collection and application of outcome data in consultations.

24 November 2025 in BMJ Open
Verified
Journal Article
Open access
HWHenrike J Westerink
Henrike J Westerink
CUCornelia F van Uden-Kraan
Cornelia F van Uden-Kraan
MGMirjam M Garvelink
Mirjam M Garvelink
DSDominique Sprengers
Dominique Sprengers
BHBarend J Hartman
Barend J Hartman
PNPaul van der Nat
Paul van der Nat
Objectives: Value-based healthcare (VBHC) strives to improve the healthcare system by focusing on value of care, that is, patient relevant outcomes relative to the costs for achieving these outcomes. Within VBHC, patient participation is crucial to identify patient relevant outcomes and value improvement potential. However, patient participation in VBHC initiatives remains limited. Therefore, we aimed to improve patient participation within VBHC teams with the ultimate aim to develop a practical guide for patient participation in VBHC. Design: An action research study. Setting: This study was conducted in seven collaborating Dutch hospitals from March 2023 to November 2024. Participants: Seven VBHC teams were selected to participate in the cyclical action research steps, that is, orientation, planning, implementation, and evaluation, in which patient participation was implemented or improved. These included the following patient groups: prostate cancer, vulnerable elderly, breast cancer, diabetes, maternity care, colorectal cancer and chronic kidney disease. Outcomes: Both qualitative and quantitative data were collected. Qualitative data included observations and minutes of meetings with the intervention teams. Quantitative data included responses to the Public and Patient Engagement Evaluation Tool (PPEET) by multiple members of the intervention (n=7) and control teams (n=94) at three time points (T1=6 months, T2=12 months, T3=end of study). Qualitative data were thematically analysed and quantitative data were analysed descriptively. Finally, the data were triangulated to create an overview of lessons learnt in improving patient participation. Results: Patient participation goals varied across teams, leading to diverse actions, such as establishing a diabetes patient panel and distributing questionnaires to patients with colorectal cancer. PPEET results show that 71% of intervention team members reported that patient participation had an impact on the team’s outcomes compared with 44% in control teams (T3). Furthermore, 80% of the intervention team members initially wanted training in patient participation (T1), which dropped to 29% at T3. Overall, 22 lessons in improving patient participation in multidisciplinary project teams were identified and compiled into a practical guide. Conclusions: The action research process improved the process and impact of patient participation in the intervention teams. Furthermore, the results indicate that the action research process enhanced the team members’ knowledge and skills on patient participation. The practical guide developed in this study can be used to support implementation of patient participation in VBHC.